GnRH receptor and apoptotic signaling

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Gonadotropin-releasing hormone (GnRH) exhibits effects beyond the pituitary, influencing extrapituitary organs and peripheral tumors.
• GnRH analogs are established treatments for advanced, metastatic, or recurrent carcinomas.
• Hormone-responsive tumors can undergo apoptosis when stimulated, with GnRH-induced growth arrest potentially linked to this process.

Purpose of the Study:

• To review recent literature and research findings on GnRH-induced membrane events.
• To summarize current knowledge regarding the antiproliferative function of GnRH in tumors.
• To elucidate the relationship between extracellular GnRH stimuli and intracellular events regulating tumor growth arrest.

Main Methods:

• Review of existing scientific literature on GnRH action in tumors.
• Analysis of studies investigating GnRH-induced membrane events and signaling pathways.
• Examination of GnRH receptor expression and function in tumor cells versus pituitary gonadotrophs.

Main Results:

• GnRH receptors are present in tumors, and their engagement triggers specific intramembranous biochemical events.
• These events include phosphotyrosine phosphatase activation and the cleavage of phosphoinositide/sphingomyelin, generating second messengers.
• GnRH increases Fas ligand expression, promoting apoptosis through the Fas-Fas ligand complex, contributing to antiproliferative effects.

Conclusions:

• GnRH-induced membrane events, including Fas ligand upregulation, are crucial for its antiproliferative action in hormone-dependent carcinomas.
• Understanding these GnRH-mediated signaling pathways can refine therapeutic strategies for apoptosis-sensitive cancers.
• GnRH receptors in tumors exhibit distinct signaling cascades compared to pituitary gonadotrophs, highlighting tumor-specific mechanisms.